Hypertension in Northern Angola: prevalence, associated factors, awareness, treatment and control
Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is ne...
Saved in:
Published in | BMC public health Vol. 13; no. 1; p. 90 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
31.01.2013
BioMed Central |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola.
A community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected.
Prevalence of hypertension (systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension.
Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease. |
---|---|
AbstractList | Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola. A community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected. Prevalence of hypertension (systolic blood pressure [greater than or equai to]140 mmHg and/or diastolic blood pressure [greater than or equai to]90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension. Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease. Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola.BACKGROUNDSeventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola.A community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected.METHODSA community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected.Prevalence of hypertension (systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension.RESULTSPrevalence of hypertension (systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension.Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease.CONCLUSIONSOur survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease. Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola. A community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected. Prevalence of hypertension (systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension. Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease. Doc number: 90 Abstract Background: Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola. Methods: A community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected. Results: Prevalence of hypertension (systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension. Conclusions: Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease. Background Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola. Methods A community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected. Results Prevalence of hypertension (systolic blood pressure [greater than or equai to]140 mmHg and/or diastolic blood pressure [greater than or equai to]90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension. Conclusions Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease. Keywords: Angola, DSS, Hypertension, Prevalence, Epidemiological transition Background: Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola. Methods: A community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected. Results: Prevalence of hypertension (systolic blood pressure > or =140 mmHg and/or diastolic blood pressure > or =90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension. Conclusions: Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease. |
ArticleNumber | 90 |
Audience | Academic |
Author | Nery, Susana V Sebastião, Yuri V Langa, António J Pires, João E |
AuthorAffiliation | 1 CISA Project (Health Research Center in Angola), Rua Direita do Caxito, Caxito, Bengo, Angola |
AuthorAffiliation_xml | – name: 1 CISA Project (Health Research Center in Angola), Rua Direita do Caxito, Caxito, Bengo, Angola |
Author_xml | – sequence: 1 givenname: João E surname: Pires fullname: Pires, João E – sequence: 2 givenname: Yuri V surname: Sebastião fullname: Sebastião, Yuri V – sequence: 3 givenname: António J surname: Langa fullname: Langa, António J – sequence: 4 givenname: Susana V surname: Nery fullname: Nery, Susana V |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23363805$$D View this record in MEDLINE/PubMed |
BookMark | eNqNks9rFTEQxxep2B969iYLXjx022TzYzcehEepVih60XOYTWZfU3aTZ5JX6X9vltZnWxQkgQyTz3wZvjOH1Z4PHqvqNSUnlPbylPKONi0XfUNZo8iz6mCX2XsQ71eHKV0TQrtetC-q_ZYxyXoiDiq4uN1gzOiTC752vv4SYr7C6OuVX4cJ3tebiDcwoTd4XENKwTjIaOsRTA4xldxPiOgxlTBHhDyjzzV4W5vgcwzTy-r5CFPCV_fvUfX94_m3s4vm8uunz2ery8aIluaG8wGtGTqBVirVMU4USgEDt8CGQTKirALLDQVlJSeC0pbY0fbtoDo5MMGOqg93upvtMBep0kaESW-imyHe6gBOP_7x7kqvw41mQineqiLw7l4ghh9bTFnPLhmcJvAYtklT1rKeynL_A12cJpT1BX37BL0O2-iLEwsllCiD6P5Q62K1dn4MpUWziOqVYFy2XApWqJO_UOVYnF2xG0dX8o8K3jz0ZGfG7_kX4PQOMDGkFHHcIZToZcP0skN62aHSrlakVIgnFcZlyG4ZNrjpn3W_AEin0pw |
CitedBy_id | crossref_primary_10_1590_2177_9465_ean_2021_0321pt crossref_primary_10_70360_rccse__v_62 crossref_primary_10_1136_bmjopen_2016_014349 crossref_primary_10_1016_j_amsu_2020_04_017 crossref_primary_10_1186_s12889_016_2759_9 crossref_primary_10_1186_s12889_016_3365_6 crossref_primary_10_1371_journal_pone_0104300 crossref_primary_10_3389_ijph_2023_1606428 crossref_primary_10_3390_healthcare9080964 crossref_primary_10_1371_journal_pone_0193494 crossref_primary_10_1093_ije_dyx279 crossref_primary_10_1016_j_ijid_2017_05_011 crossref_primary_10_1080_16549716_2017_1321279 crossref_primary_10_2147_RMHP_S432943 crossref_primary_10_1093_ije_dyx072 crossref_primary_10_1155_2018_8307591 crossref_primary_10_1371_journal_pone_0188586 crossref_primary_10_1371_journal_pone_0219377 crossref_primary_10_1186_s12872_019_01273_7 crossref_primary_10_1177_20503121221104442 crossref_primary_10_1590_2177_9465_ean_2021_0321en crossref_primary_10_4137_CMC_S39561 crossref_primary_10_2147_IBPC_S432251 crossref_primary_10_4102_phcfm_v10i1_1758 crossref_primary_10_1186_1471_2458_14_386 crossref_primary_10_1186_s12889_022_14026_7 crossref_primary_10_1111_tmi_12443 crossref_primary_10_3917_spub_222_0289 crossref_primary_10_1177_20503121211024519 crossref_primary_10_1186_s12889_015_2546_z crossref_primary_10_3389_fcvm_2024_1403214 crossref_primary_10_4103_aam_aam_20_20 crossref_primary_10_1186_1471_2261_13_54 crossref_primary_10_1161_HYPERTENSIONAHA_114_04394 crossref_primary_10_1371_journal_pone_0215500 crossref_primary_10_1186_1471_2458_14_893 crossref_primary_10_1155_2020_9032476 crossref_primary_10_1111_jch_12863 crossref_primary_10_1371_journal_pone_0218052 crossref_primary_10_1038_jhh_2017_18 crossref_primary_10_1371_journal_pone_0205985 crossref_primary_10_1111_jch_13873 crossref_primary_10_1097_HJH_0000000000002165 crossref_primary_10_1097_HJH_0000000000001312 crossref_primary_10_1371_journal_pone_0192942 crossref_primary_10_2174_1874944501710010148 crossref_primary_10_4236_jbm_2022_105017 crossref_primary_10_1186_s12889_016_3008_y crossref_primary_10_1007_s40292_015_0114_3 crossref_primary_10_1159_000381453 crossref_primary_10_1186_s12889_016_3926_8 |
Cites_doi | 10.1161/HYPERTENSIONAHA.107.093336 10.1097/00004872-200311000-00002 10.1097/01.mbp.0000209078.17246.34 10.1097/00004872-200018020-00003 10.1016/j.jacc.2012.04.026 10.1161/01.HYP.0000126176.03319.d8 10.1371/journal.pone.0033189 10.1097/00004872-200303000-00016 10.1016/j.jacc.2008.08.049 10.1038/sj.jhh.1001924 10.1097/HJH.0b013e3283282f65 10.1016/S0140-6736(05)70151-3 10.1186/1471-2458-10-569 10.1038/oby.2002.141 10.1080/14034940500204506 10.1038/sj.jhh.1001923 10.1161/HYPERTENSIONAHA.109.132423 10.1097/HJH.0b013e328346995d |
ContentType | Journal Article |
Copyright | COPYRIGHT 2013 BioMed Central Ltd. 2013 Pires et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ©2013 Pires et al.; licensee BioMed Central Ltd. 2013 Pires et al.; licensee BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2013 BioMed Central Ltd. – notice: 2013 Pires et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright ©2013 Pires et al.; licensee BioMed Central Ltd. 2013 Pires et al.; licensee BioMed Central Ltd. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T2 7X7 7XB 88E 8C1 8FE 8FG 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA AN0 ATCPS AZQEC BENPR BGLVJ BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. L6V M0S M1P M7S PATMY PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY 7X8 7U1 5PM |
DOI | 10.1186/1471-2458-13-90 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health and Safety Science Abstracts (Full archive) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland British Nursing Database (Proquest) Agricultural & Environmental Science Collection ProQuest Central Essentials ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Engineering Collection ProQuest Health & Medical Collection Medical Database Engineering Database Environmental Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering collection Environmental Science Collection MEDLINE - Academic Risk Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Collection ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection ProQuest Engineering Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Engineering Database ProQuest Public Health ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Environmental Science Collection ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Materials Science & Engineering Collection Environmental Science Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Risk Abstracts |
DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database Risk Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1471-2458 |
EndPage | 90 |
ExternalDocumentID | PMC3599429 2914053531 A534624653 23363805 10_1186_1471_2458_13_90 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Angola Africa |
GeographicLocations_xml | – name: Angola – name: Africa |
GroupedDBID | --- 0R~ 23N 2WC 2XV 4.4 44B 53G 5VS 6J9 6PF 7X7 7XC 88E 8C1 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABJCF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AN0 AOIJS ATCPS BAPOH BAWUL BCNDV BENPR BFQNJ BGLVJ BHPHI BMC BNQBC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IHR INH INR IPNFZ ITC KQ8 L6V M1P M48 M7S M~E O5R O5S OK1 OVT P2P PATMY PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RBZ RIG RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PMFND 3V. 7T2 7XB 8FK AZQEC C1K DWQXO GNUQQ K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7X8 7U1 5PM |
ID | FETCH-LOGICAL-c521t-44bedcb75ed69973409e65ab4da3bb6309d9ad4c1a9d64051120dfd82b976b353 |
IEDL.DBID | M48 |
ISSN | 1471-2458 |
IngestDate | Thu Aug 21 14:13:12 EDT 2025 Mon Jul 21 11:17:55 EDT 2025 Fri Jul 11 03:39:21 EDT 2025 Fri Jul 25 10:49:20 EDT 2025 Tue Jun 17 22:05:30 EDT 2025 Tue Jun 10 21:03:09 EDT 2025 Thu Apr 03 07:03:48 EDT 2025 Thu Apr 24 22:50:48 EDT 2025 Tue Jul 01 04:09:29 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | http://www.springer.com/tdm This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c521t-44bedcb75ed69973409e65ab4da3bb6309d9ad4c1a9d64051120dfd82b976b353 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/1471-2458-13-90 |
PMID | 23363805 |
PQID | 1315956387 |
PQPubID | 44782 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3599429 proquest_miscellaneous_1323816816 proquest_miscellaneous_1317850138 proquest_journals_1315956387 gale_infotracmisc_A534624653 gale_infotracacademiconefile_A534624653 pubmed_primary_23363805 crossref_primary_10_1186_1471_2458_13_90 crossref_citationtrail_10_1186_1471_2458_13_90 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-01-31 |
PublicationDateYYYYMMDD | 2013-01-31 |
PublicationDate_xml | – month: 01 year: 2013 text: 2013-01-31 day: 31 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC public health |
PublicationTitleAlternate | BMC Public Health |
PublicationYear | 2013 |
Publisher | BioMed Central Ltd BioMed Central |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central |
References | World Health Organization (5061_CR16) 2000; 894 T Puoane (5061_CR27) 2002; 10 J Mufunda (5061_CR19) 2006; 20 M Pereira (5061_CR6) 2009; 27 World Health Organization (5061_CR2) 2009 Instituto Nacional de Estatística (5061_CR13) 2008 PM Kearney (5061_CR5) 2005; 365 JF Wamala (5061_CR25) 2009; 9 JA Topouchian (5061_CR15) 2006; 11 JC Sousa-Figueiredo (5061_CR12) 2012; 7 W Mathenge (5061_CR24) 2010; 10 R Edwards (5061_CR26) 2000; 18 N Ng (5061_CR8) 2006; 34 C Agyemang (5061_CR21) 2006; 24 JA Whitworth (5061_CR28) 2003; 21 FP Cappuccio (5061_CR22) 2004; 43 5061_CR14 5061_CR7 5061_CR11 J Addo (5061_CR4) 2007; 50 5061_CR17 F Guo (5061_CR20) 2012; 60 World Health Organization (5061_CR1) 2010 R Joshi (5061_CR23) 2008; 52 A Damasceno (5061_CR18) 2009; 54 P Bovet (5061_CR29) 2003; 21 World Health Organization (5061_CR9) 2011 5061_CR10 M Twagirumukiza (5061_CR3) 2011; 29 14597836 - J Hypertens. 2003 Nov;21(11):1983-92 21540748 - J Hypertens. 2011 Jul;29(7):1243-52 22493664 - PLoS One. 2012;7(4):e33189 16581713 - Scand J Public Health. 2006;34(2):199-208 10694181 - J Hypertens. 2000 Feb;18(2):145-52 16151443 - J Hum Hypertens. 2006 Jan;20(1):59-65 15037552 - Hypertension. 2004 May;43(5):1017-22 19038678 - J Am Coll Cardiol. 2008 Dec 2;52(23):1817-25 20860807 - BMC Public Health. 2010;10:569 11234459 - World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253 16702826 - Blood Press Monit. 2006 Jun;11(3):165-71 12640244 - J Hypertens. 2003 Mar;21(3):509-17 19470872 - Hypertension. 2009 Jul;54(1):77-83 22796254 - J Am Coll Cardiol. 2012 Aug 14;60(7):599-606 12376585 - Obes Res. 2002 Oct;10(10):1038-48 20589143 - Afr Health Sci. 2009 Sep;9(3):153-60 15652604 - Lancet. 2005 Jan 15-21;365(9455):217-23 17954720 - Hypertension. 2007 Dec;50(6):1012-8 19402221 - J Hypertens. 2009 May;27(5):963-75 16121199 - J Hum Hypertens. 2006 Jan;20(1):67-71 |
References_xml | – volume: 50 start-page: 1012 year: 2007 ident: 5061_CR4 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.107.093336 – volume: 21 start-page: 1983 year: 2003 ident: 5061_CR28 publication-title: J Hypertens doi: 10.1097/00004872-200311000-00002 – volume-title: Non comunicable diseases country profiles year: 2011 ident: 5061_CR9 – volume: 894 start-page: 1 year: 2000 ident: 5061_CR16 publication-title: World Health Organ Tech Rep Ser – volume: 11 start-page: 165 year: 2006 ident: 5061_CR15 publication-title: Blood Press Monit doi: 10.1097/01.mbp.0000209078.17246.34 – volume: 18 start-page: 145 year: 2000 ident: 5061_CR26 publication-title: J Hypertens doi: 10.1097/00004872-200018020-00003 – volume: 60 start-page: 599 year: 2012 ident: 5061_CR20 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.04.026 – volume-title: Global health risks: mortality and burden of disease attributable to selected major risks year: 2009 ident: 5061_CR2 – ident: 5061_CR11 – volume: 43 start-page: 1017 year: 2004 ident: 5061_CR22 publication-title: Hypertension doi: 10.1161/01.HYP.0000126176.03319.d8 – volume: 9 start-page: 153 year: 2009 ident: 5061_CR25 publication-title: Afr Health Sci – volume: 7 start-page: e33189 year: 2012 ident: 5061_CR12 publication-title: PLoS One doi: 10.1371/journal.pone.0033189 – ident: 5061_CR17 – volume: 21 start-page: 509 year: 2003 ident: 5061_CR29 publication-title: J Hypertens doi: 10.1097/00004872-200303000-00016 – volume: 52 start-page: 1817 year: 2008 ident: 5061_CR23 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2008.08.049 – ident: 5061_CR7 – volume-title: Manual de Instruções do Inquiridor year: 2008 ident: 5061_CR13 – volume: 20 start-page: 59 year: 2006 ident: 5061_CR19 publication-title: J Hum Hypertens doi: 10.1038/sj.jhh.1001924 – volume: 27 start-page: 963 year: 2009 ident: 5061_CR6 publication-title: J Hypertens doi: 10.1097/HJH.0b013e3283282f65 – volume: 365 start-page: 217 year: 2005 ident: 5061_CR5 publication-title: Lancet doi: 10.1016/S0140-6736(05)70151-3 – volume: 10 start-page: 569 year: 2010 ident: 5061_CR24 publication-title: BMC Public Health doi: 10.1186/1471-2458-10-569 – volume: 10 start-page: 1038 year: 2002 ident: 5061_CR27 publication-title: Obes Res doi: 10.1038/oby.2002.141 – volume-title: Global status report on noncommunicable diseases year: 2010 ident: 5061_CR1 – ident: 5061_CR10 – volume: 34 start-page: 199 year: 2006 ident: 5061_CR8 publication-title: Scand J Public Health doi: 10.1080/14034940500204506 – ident: 5061_CR14 – volume: 24 start-page: 67 year: 2006 ident: 5061_CR21 publication-title: J Hum Hypertens doi: 10.1038/sj.jhh.1001923 – volume: 54 start-page: 77 year: 2009 ident: 5061_CR18 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.109.132423 – volume: 29 start-page: 1243 year: 2011 ident: 5061_CR3 publication-title: J Hypertens doi: 10.1097/HJH.0b013e328346995d – reference: 12640244 - J Hypertens. 2003 Mar;21(3):509-17 – reference: 19470872 - Hypertension. 2009 Jul;54(1):77-83 – reference: 15037552 - Hypertension. 2004 May;43(5):1017-22 – reference: 16581713 - Scand J Public Health. 2006;34(2):199-208 – reference: 21540748 - J Hypertens. 2011 Jul;29(7):1243-52 – reference: 20860807 - BMC Public Health. 2010;10:569 – reference: 22493664 - PLoS One. 2012;7(4):e33189 – reference: 12376585 - Obes Res. 2002 Oct;10(10):1038-48 – reference: 14597836 - J Hypertens. 2003 Nov;21(11):1983-92 – reference: 17954720 - Hypertension. 2007 Dec;50(6):1012-8 – reference: 20589143 - Afr Health Sci. 2009 Sep;9(3):153-60 – reference: 16121199 - J Hum Hypertens. 2006 Jan;20(1):67-71 – reference: 16151443 - J Hum Hypertens. 2006 Jan;20(1):59-65 – reference: 16702826 - Blood Press Monit. 2006 Jun;11(3):165-71 – reference: 19038678 - J Am Coll Cardiol. 2008 Dec 2;52(23):1817-25 – reference: 19402221 - J Hypertens. 2009 May;27(5):963-75 – reference: 11234459 - World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253 – reference: 22796254 - J Am Coll Cardiol. 2012 Aug 14;60(7):599-606 – reference: 15652604 - Lancet. 2005 Jan 15-21;365(9455):217-23 – reference: 10694181 - J Hypertens. 2000 Feb;18(2):145-52 |
SSID | ssj0017852 |
Score | 2.2984657 |
Snippet | Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now... Background Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension... Doc number: 90 Abstract Background: Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and... Background: Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as... |
SourceID | pubmedcentral proquest gale pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 90 |
SubjectTerms | Adolescent Adult Age Distribution Angola Angola - epidemiology Awareness Blood pressure Cardiovascular diseases Care and treatment Chronic diseases Disease Economic growth Epidemiology Female Field study Follow-Up Studies Health Knowledge, Attitudes, Practice Health policy Health risks Humans Hypertension Hypertension - epidemiology Hypertension - prevention & control Hypertension - therapy Male Medical research Medicine, Experimental Middle Aged Mortality Physiological aspects Population Prevalence Prevalence studies (Epidemiology) Prevention Public health Risk Factors Sex Distribution Surveys Tobacco Tropical diseases Young Adult |
SummonAdditionalLinks | – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1di9QwcNDzRRDx2-opEQR9uHht89HGF1nEdRH0yYN7C0mTegeSXffu8O8702brVvCgT820TTPfmckMwOtoTFBoRnNdV5EjJ0ZuXCl5F7wilKPTRYeTv37TqxP55VSd5g23i5xWuZOJg6AO6472yI8rgYpXIbU0Hza_OHWNouhqbqFxE25VqGkopatdfp6iCE2r6lzOp2r1cYWCmNdSodskOAnhPU30rzzeU0jzZMk97bO8B3ez2cgWI57vw42YHsCdcc-NjUeJHoJboVO5HVLS14mdJzYEZeI2sUX6gS7se7bZUnVvYuYj5jJiYmC56Q7e-01nw1D4HbEpA525FFjOaH8EJ8tP3z-ueG6hwDvqVMCl9Dhz36gYtDGNQG8uauW8DE54r0VpgnFBdpUzQaPthtZXGfrQ1h7NFC-UeAwHaZ3iU2B9r_rQdL3TjZdOOK-i9rInD82rumsLeLdbTtvl-uLU5uKnHfyMVltaf0vrbythTVnA2-mBzVha4_-gbwg_lpgO39m5fHYAZ0blq-xCCalrKhVXwOEMEpmlmw_vMGwzs17Yv6RVwKtpmJ6kBLQU11cDDFIThXWvgyH7R-NVwJORaKYfq4XAD5SqgGZGThMAlfmej6Tzs6Hct1DGoNXw7PqpP4fb9dCpo0K1eggHl9ur-ALtpUv_cmCKP6vkFPA priority: 102 providerName: ProQuest |
Title | Hypertension in Northern Angola: prevalence, associated factors, awareness, treatment and control |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23363805 https://www.proquest.com/docview/1315956387 https://www.proquest.com/docview/1317850138 https://www.proquest.com/docview/1323816816 https://pubmed.ncbi.nlm.nih.gov/PMC3599429 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF-0fRFE_G60HisI-tDUJPuVFUSupechtEjx4PAl7GY3Wih7Nbao_70zm1zaSC2EfchOvmZndmays_Mj5JXX2glwo1NZ5D4FTfSpNhlPa2cFDjkEXbg5-fBIzhf801IsL-GAegb-vDa0QzypRXu6-_vHnw-g8O-jwpfybQ4TbFpwAeEQSzXE75tglhTCGRzyyyUFVUb4nYG4r_NzzQ1GJurfifqKpRpnUV4xS7P75F7vT9JpJwAPyC0fHpK73c842u0xekTMHKLNNuaqrwI9CTSu1vg20Gn4Bgx4R89aLPuNWr5DTT9i3tEejQfO_cJNYzAr7tAhNZ2a4Gif6v6YLGYHX_bnaY-tkNYIYZBybuHNrRLeSa0VgzDPS2Esd4ZZK1mmnTaO17nRToJTB25Z5hpXFhb8F8sEe0I2wir4LUKbRjRO1Y2RynLDjBVeWt5g6GZFUZcJ2V2zs6r7wuOIf3FaxQCklBXyv0L-VzmrdJaQN8MFZ13Njf-TvsbxqVA-4J616TcVwJthXatqKhiXBdaQS8j2iBK0qB53r0e4WgshPAKcPQEzlErIy6Ebr8TMtOBXF5EGJAvXe2-iQcdIwpGQp53QDB9WMAYPyERC1EicBgKs_z3uCSffYx1wJrQGd-LZzV_2nNwpIoRHDvZ2m2yctxf-BThS53ZCbqulgrbcz7GdfZyQzb2Do8_Hk_hrYhIVCNrjva9_Abv-HwQ |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELaq8gASQtwEChgJBA8NTXwlRkJoBSxbejy1Ut9cO3agEvIu21YVf4rfyEwuNkj0rVKe4sllz3wzE89ByMugtZdgRqeK5SEFSQyptplIK-8kLjk4XZicvLevZofi65E8WiO_-1wYDKvsMbEBaj-v8B_5Vs5B8UrgluLD4meKXaNwd7VvodGyxU74dQEu2-n77U-wvq8Ym34--DhLu64CaYXF-1MhXPCVK2TwSuuCg4MTlLROeMudUzzTXlsvqtxqr8CcAYMk87UvmQPN7ZouEQD51wQHTY6Z6dMvw65FUUrWlQ_KS7WVA_CnTEhw03iKoL-i-f7F_xUFOA7OXNF209vkVmem0knLV3fIWoh3yc32Hx9tU5fuETsDJ3bZhMDPIz2JtNkECstIJ_EbuMzv6GKJ1cQRPDap7RgheNo1-YFzF5iLBmC7SYeId2qjp10E_X1yeCWT-4Csx3kMjwita1n7oqqtKpyw3DoZlBM1eoROsqpMyNt-Ok3V1TPHtho_TOPXlMrg_Bucf5Nzo7OEvBkuWLSlPP5P-hrXx6CQwz0r2-UqwJthuSwzkVwohqXpErIxogThrMbD_QqbDhxOzV9WTsiLYRivxIC3GObnDQ1wE24jX0aD9paCIyEPW6YZPoxxDg_IZEKKETsNBFhWfDwST7435cW51BqslMeXv_pzcn12sLdrdrf3d56QG6zpEpKDSt8g62fL8_AUbLUz96wREEqOr1oi_wCJX1H2 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypertension+in+Northern+Angola%3A+prevalence%2C+associated+factors%2C+awareness%2C+treatment+and+control&rft.jtitle=BMC+public+health&rft.au=Pires%2C+Jo%C3%83%C2%A3o+E&rft.au=Sebasti%C3%83%C2%A3o%2C+Yuri+V&rft.au=Langa%2C+Ant%C3%B3nio+J&rft.au=Nery%2C+Susana+V&rft.date=2013-01-31&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2458&rft.eissn=1471-2458&rft.volume=13&rft_id=info:doi/10.1186%2F1471-2458-13-90&rft.externalDocID=A534624653 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2458&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2458&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2458&client=summon |